The global small animal imaging in-vivo market size is estimated to register a significant CAGR over the forecast period, 2021-2028. The growth of the market is attributed to the growing application of in-vivo imaging and the increasing number of research organizations. In-vivo imaging has high-resolution modalities and provides data storage in real-time that are other factors fueling the further market expansion.
The in-vivo imaging system includes a range of instruments that are not introduced or invaded in the body while using for diagnostic or research purposes. These devices are used for various applications including evaluation of new molecules for bio-distribution patterns, monitoring the response given by drugs during the development of new drugs, and research for the cancer cell. Small animal imaging in-vivo has different modalities that are achieving remarkable consequences regards to receptor targeting, providing the definition of action mechanism, and research studies related to epigenetic. The use and development of multimodal instruments is expected to exhibit rapid growth both in preclinical and clinical phases due to ongoing technological evolution.
Various imaging can be performed using non-invasive modalities that include molecular, structural, and functional imaging. The introduction of rarefaction technology along with the development of novel instruments are anticipated to drive the overall market expansion due to the increasing usage of molecular imaging in biology & medicine. The primary objective of molecular imaging using non-invasive methods is to quantify, visualize, and characterize the pathological & normal biological activities at sub-cellular or cellular levels that occur in the living organisms.
Market Trends, Drivers, Restraints, and Opportunities
- Growing demand for in-vivo imaging techniques and their applications in various domains is anticipated to fuel the market growth during the forecast period.
- Technological innovations along with the technological advancements in molecular imaging research are expected to propel the market growth in the coming years.
- Existing strict regulatory frameworks coupled with the presence of complex reimbursement policies across countries are major challenges that can restrain the market expansion.
- Increasing number of healthcare initiatives by both public & private sector in order to support researches are estimated to fuel the market growth over the forecast period.
- Ongoing research & development and wide investments from key pharmaceutical companies are projected to create lucrative opportunities for the market expansion.
Scope of the Report
The report on the global small animal imaging in-vivo market includes an assessment of the market, trends, and segments. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Small Animal Imaging In-vivo Market – Global Industry Analysis, Growth, Share, Size, Trends, And Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018–2019
|
|
Forecast Period
|
2021–2028
|
|
Segmentation
|
Technology (Nuclear Imaging, Optical Imaging, Micro-magnetic Resonance Imaging, and Other Imaging Modalities [Micro-ultrasound and Micro-CT]) and Applications (Cancer Cell Detection, Monitoring Treatment Response, Biomarkers, Bio-distribution, Epigenetics, and Longitudinal Studies)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Aspect Imaging Ltd.; Miltenyi Biotec GmbH; FujiFilm Holding Corp.; Life Technologies Corp.; Siemens AG; Thermo Fisher Scientific; PerkinElmer Inc.; Bruker Corp.; and Promega Corp., Inc.
|
Market Segment Insights
Micro-magnetic resonance imaging segment is anticipated to expand at a high CAGR
On the basis of technology, the global small animal imaging in-vivo market is divided into nuclear imaging, optical imaging, micro-magnetic resonance imaging, and other imaging modalities. The other imaging modalities segment is further bifurcated into micro-ultrasound and micro-CT. The optical imaging segment held a major share of the market in 2019 and is expected to account for a key market share in the coming years owing to its cost-effectiveness along with easy & rapid operations as compared to other modalities. However, the micro-magnetic resonance imaging segment is anticipated to expand at a high CAGR attributed to its specific & precise operations that provide better results in the preclinical research phase.
Cancer cell detection segment is estimated to grow at a rapid pace
Based on applications, the market is segmented into cancer cell detection, monitoring treatment response, biomarkers, bio-distribution, epigenetics, and longitudinal studies. The bio-distribution segment held a key share of the market in 2019 and is expected to continue its dominance of the market in the coming years. However, cancer cell detection segment is estimated to grow at a rapid pace owing to the increasing incidence of cancer cases across the globe.
North America is anticipated to dominate the market
In terms of regions, the global small animal imaging in-vivo market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a major share of the market in 2019 and is anticipated to dominate the market during the forecast period attributed to technological advancements and innovations made for innovative modalities. Various numbers of preclinical researches in the region is also expected to fuel the market expansion. North America is followed by Europe as the second large market attributed to the presence of pharmaceutical organizations, clinical research, and a huge number of manufacturers of diagnostic devices in the latter region. On the other hand, the market of Asia Pacific is also estimated to grow at a rapid pace during the forecast period due to changes in clinical research activities.
Segments
The global small animal imaging in-vivo market has been segmented on the basis of
Technology
- Nuclear Imaging
- Optical Imaging
- Micro-magnetic Resonance Imaging
- Other Imaging Modalities
- Micro-ultrasound
- Micro-CT
Applications
- Cancer Cell Detection
- Monitoring Treatment Response
- Biomakers
- Bio-distribution
- Epigebetics
- Longitudinal Studies
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Aspect Imaging Ltd.
- Miltenyi Biotec GmbH
- FujiFilm Holding Corp.
- Life Technologies Corp.
- Siemens AG
- Thermo Fisher Scientific
- PerkinElmer Inc.
- Bruker Corp.
- Promega Corp., Inc.
Competitive Landscape
Key players competing in the global small animal imaging in-vivo market are Aspect Imaging Ltd.; Miltenyi Biotec GmbH; FujiFilm Holding Corp.; Life Technologies Corp.; Siemens AG; Thermo Fisher Scientific; PerkinElmer Inc.; Bruker Corp.; and Promega Corp., Inc. Many of these players have adopted business strategies such as launching new products, advancement of technology, partnerships, mergers, and production capacity expansion in order to increase their expansion, their consumer base, and market position globally.
Request For Customization
Enquiry Before Buying
Speak With Analyst
